SLS

Conviction 87HealthcareScan · Fri, Aug 7, 2026

SLS$12.00+2.52%

ResistanceSupportVol 14

Vol MA14 6.25M

May 8May 27Jun 15Jul 2Jul 22Aug 7

WSB mentions · 24h changelatest +133.33%· 7 mentions

May 8May 27Jun 15Jul 2Jul 22Aug 7

SELLAS Life Sciences Group, Inc.PHARMACEUTICAL PREPARATIONSwww.sellaslifesciences.com ↗

Price12.00

Change+2.52%

Gap+2.05%

Rel volume1.37×

Avg volume6.66M

Avg $ vol78.29M

SMA 2011.74

SMA 5010.82

SMA 2005.64

Price vs 50+10.82%

Price vs 200+112.60%

MA stackbullish

50/200 cross—

Supertrenddown · 13.93

RSI (14)54

MACD hist-0.05

MACD cross—

Stoch %K / %D69 / 62

ADX (14)25

+DI / −DI23 / 16

RSI divergence—

MACD divergence—

ATR %+9.37%

ADR %9.28%

52w high15.45

52w low1.39

From 52w high-22.36%

Above 52w low+762.95%

New 52w highNo

SqueezeOff

Bollinger width34.85%

%B0.56

Donchian pos61.78%

Donchian high13.73

Donchian low9.19

AVWAP (52w high)12.67

vs AVWAP high-5.36%

AVWAP (52w low)6.61

vs AVWAP low+81.58%

OBV trendFlat

Chaikin MF (20)0.07

Today vs 20d1.37×

Avg vol (14d)6.25M

Avg vol (20d)6.66M

Avg $ vol (20d)78.29M

Market cap2.23B

RS 3m (vs SPY)+122.45%

RS 6m (vs SPY)+194.28%

RS line new highNo

Trend template8/8

Technical rank80.3

1 week+19.83%

1 month-11.21%

3 months+143.31%

6 months+239.80%

1 year+654.40%

YTD+175.75%

P/E-83.07

P/B20.77

P/S—

P/FCF-78.59

EPS-0.2500

Div yield—

ROE-25.01%

ROA-23.53%

Debt/Eq0.00

Current17.22

EV/EBITDA-75.51

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth13.01%

Price target27.50

Target upside129.26%

Analyst ratingBuy

Institutional38.03%

Ent. value2.12B

Revenue0

Net income-8.41M

Gross profit869K

Free cash flow-28.39M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out196.63M

Employees13

ListedWed, Mar 12, 2008

Free float182.12M

Float %98.7%

Short interest55.28M

Days to cover5.9d

Short volume52.4%

Squeeze score79 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction87 / 100

Pattern quality—

Tech rank80.3 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance15.72

Support8.31

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 45 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Jun 4
1 scan
→
Breaking out now
Jun 25
1 scan

Congress activity

Disclosed STOCK Act trades in SLS

All disclosures →

No recent disclosed trades by Congress in SLS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SLS · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Stergiou Angelos M. President and CEO · Common Stock · 2026-06-16	Grant	1.06M	—	2026-06-16	2026-06-18

SEC filings

EDGAR filings in SLS · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.